Skip to main content

2023 PharmSci 360 Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Mark Qian, Ph.D. (he/him/his)

Takeda Pharmaceutical Company Limited

Poster(s):

(T1430-06-36) Immunogenicity Assessment: A Comparative Study between a Chemically Labeled and an Enzymatically Biotinylated rAAV9 Vector

Tuesday, October 24, 2023
2:30 PM – 3:30 PM ET